Issue Date: November 1, 1989
Issued by: Center for Drug Evaluation and Research
Topic(s): Clinical – Medical
Status: Final
The FDA published Good Guidance Practices in February 1997. This guidance was developed and issued prior to that date.
Download the Guidance Document
Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant analytical and bioanalytical services to support drug development. From early discovery through clinical development and commercialization, we provide CGMP and GLP-compliant services tailored to your therapeutic modality and regulatory needs.
